Director of Oncology Teaching and Research Office of Nanjing Medical University, Director of Jiangsu Translational Cancer Center for Clinical Medicine, Deputy Director of Cancer Research Center of Nanjing Medical University. He is the academic leader of oncology in Jiangsu Province. He has published more than 70 research papers, edited 3 monographs, and won provincial and departmental scientific and technological achievements four times. In recent years, he has been mainly engaged in the research of new targets for personalized diagnosis and treatment of non-small cell lung cancer, early screening of gastric cancer and genetic strategies for personalized treatment, and molecular immunotherapy of malignant tumors.

Administrative positions:

Director of Oncology Department, Jiangsu Provincial People's Hospital

Director of Oncology Teaching and Research Office, Nanjing Medical University

Director of Jiangsu Cancer Translational Clinical Medicine Center

Deputy Director, Cancer Research Center, Nanjing Medical University


Social work:

Chairman of Jiangsu Provincial Committee of Biological Diagnosis and Therapy

Chairman of the Committee of Tumor Immunity, Jiangsu Society of Immunology

Chairman of the Professional Committee of Tumor Biological Diagnosis and Treatment of Jiangsu Biotechnology Association

National Committee of Chinese Medical Association

CSCO Executive Committee

Vice Chairman of National Cancer Hyperthermia Alliance

Member of the International Lung Cancer Federation Professional Committee

Member of the Standing Committee of the Gastric Cancer Committee of the Chinese Anti-Cancer Society

Executive Director of Jiangsu Society of Immunology

Executive Director of Jiangsu Anti-Cancer Association

Vice Chairman of Nanjing Cancer Society

Executive Director of Jiangsu Anti-Cancer Association


Talent title:

Provincial "333" second-level training object

Leading Talents of Oncology in Jiangsu Province

Head of Jiangsu Oncology Innovation Team


Awards:

China Medical Science and Technology Third Prize: Research on the treatment and prognosis of non-small cell lung cancer guided by molecular markers

Second Prize of Jiangsu Science and Technology Progress Award: The role of related gene detection in early gastric cancer screening and individualized treatment

Third Prize of Chinese Medical Science and Technology: Research on genetic strategies for early screening and individualized treatment of gastric cancer

First Prize of Jiangsu Medical Science and Technology Award: Basic and clinical research on the regulation of apoptosis-related genes in malignant tumors

First Prize of Jiangsu Medical Science and Technology Award: Research on the mechanism and application of microRNA and important signaling molecules in tumor resistance

The First Prize of Jiangsu Medical Science and Technology: Research on the treatment and prognosis of non-small cell lung cancer guided by molecular markers

Application of Cripto Gene Test in the Diagnosis and Prognosis Evaluation of Colorectal Cancer, Second Prize of Jiangsu Medical Science and Technology

First Prize of New Technology Introduction from Jiangsu Health Department: Clinical study of tamoxifen combined with rapamycin in the treatment of liver cancer

The first prize of the Jiangsu Department of Health New Technology Introduction Award: The clinical value of quality of life assessment combined with immune function testing for targeted therapy in patients with advanced renal cancer

The First Prize of New Technology Introduction from Jiangsu Department of Health: Evaluation of IGF1 and microRNA-196a2 gene polymorphisms on the susceptibility and prognosis of lung cancer in Chinese population

Basic research and clinical application of new targets for personalized diagnosis and treatment of non-small cell lung cancer, Second Prize of Nanjing Science and Technology Progress Award

First Prize of New Technology Introduction Award of Jiangsu Department of Health: Application of miRNA in the clinical diagnosis and treatment of malignant tumors

China Anti-Cancer Association Science and Technology Award Biological target-guided personalized diagnosis and treatment of non-small cell lung cancer


Publish articles and undertake topics:

In recent years, he has published more than 120 SCI articles and four monographs. Undertake 3 national natural science fund projects, national health ministry projects, national "863" projects, major research projects of the Provincial Department of Health and major research projects of the Provincial Science and Technology Commission and the Provincial Education Commission. It has undertaken 8 international multi-center clinical new drug clinical phase II-III studies, 15 domestic multi-center clinical new drug phase II-III studies, and undertook multiple clinical phase IV studies.


Main direction:

Since 1994, he has been engaged in basic and clinical research in clinical oncology, focusing on the diagnosis and treatment of lung cancer and digestive system tumors. In recent years, he has been mainly engaged in the research of new targets for personalized diagnosis and treatment of non-small cell lung cancer, early screening of gastric cancer and genetic strategies for personalized treatment, and molecular immunotherapy of malignant tumors.